LIQTLIQT flags Nasdaq bid-price deficiency with January 2027 compliance deadlineJul 25FUSEFUSE in focus: Fusemachines draws Nasdaq deficiency notice on market value, has until January 20, 2027 to complyJul 25SLNHSoluna Holdings sets CEO Belizaire's base salary at $600,000, retroactive to January, with 100% bonus targetJul 25MDMD names David Haddock general counsel as Mary Ann Moore's Pediatrix exit takes formal shapeJul 25MARKETSSSD declares $0.30 quarterly cash dividend, ex-date and record date set for October 1Jul 25MARKETSBLUBF declares CAD 0.04 monthly cash dividend with August 31 ex-dateJul 25CNXCConcentrix CNXC board adopts amended severance plan with 2x change-of-control payout and new standalone benefitJul 24QSIQSI in focus: Quantum-Si receives Nasdaq minimum bid price notice, faces January 19 compliance deadlineJul 24INSPInspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointmentJul 24MARKETSCapital expenditure in focus as Alphabet raises the AI spending bar, three hyperscalers left to reportJul 24LIQTLIQT flags Nasdaq bid-price deficiency with January 2027 compliance deadlineJul 25FUSEFUSE in focus: Fusemachines draws Nasdaq deficiency notice on market value, has until January 20, 2027 to complyJul 25SLNHSoluna Holdings sets CEO Belizaire's base salary at $600,000, retroactive to January, with 100% bonus targetJul 25MDMD names David Haddock general counsel as Mary Ann Moore's Pediatrix exit takes formal shapeJul 25MARKETSSSD declares $0.30 quarterly cash dividend, ex-date and record date set for October 1Jul 25MARKETSBLUBF declares CAD 0.04 monthly cash dividend with August 31 ex-dateJul 25CNXCConcentrix CNXC board adopts amended severance plan with 2x change-of-control payout and new standalone benefitJul 24QSIQSI in focus: Quantum-Si receives Nasdaq minimum bid price notice, faces January 19 compliance deadlineJul 24INSPInspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointmentJul 24MARKETSCapital expenditure in focus as Alphabet raises the AI spending bar, three hyperscalers left to reportJul 24

LIQT flags Nasdaq bid-price deficiency with January 2027 compliance deadline

LIQT is in focus after LiqTech International, Inc. received a deficiency notice from The Nasdaq Stock Market on July 21, 2026, citing failure to meet the $1.00 minimum bid price required for continued listing under Nasdaq Listing Rule 5550(a)(2). The stock's closing bid price ran below that threshold for 30 consecutive business days before the notice date. The next hard date on the calendar is January 19, 2027.

By Jonah BergMacro DeskJuly 25, 20262 min readLIQT
Share

LIQT is in focus after LiqTech International, Inc. received a deficiency notice from The Nasdaq Stock Market on July 21, 2026, citing failure to meet the $1.00 minimum bid price required for continued listing under Nasdaq Listing Rule 5550(a)(2). The stock's closing bid price ran below that threshold for 30 consecutive business days before the notice date. The next hard date on the calendar is January 19, 2027.

What the 8-K discloses

The current report, signed by Chief Executive Officer Fei Chen and filed July 24, 2026, is clear on the immediate trading picture. Common stock remains listed on The Nasdaq Capital Market under the symbol LIQT. The deficiency notice itself carries no immediate delisting action.

That framing matters less than the compliance math. Under Nasdaq Listing Rule 5810(c)(3)(A), LiqTech has an initial 180-calendar-day window to fix the problem. Clearing the bar requires the closing bid price to reach $1.00 or above for a minimum of 10 consecutive business days before January 19, 2027.

The second-chance structure

A second 180-day extension is available if the first period expires without compliance, but the conditions tighten. LiqTech would need to meet the continued listing requirement for market value of publicly held shares and satisfy all other initial listing standards for The Nasdaq Capital Market, with the minimum bid price requirement as the sole exception. The company would also be required to submit written notice to Nasdaq stating its intention to cure the deficiency during the second compliance period.

Failing to qualify for the extension, or exhausting it without result, would trigger a formal delisting determination. An appeal to a Hearings Panel would be the company's remaining procedural option before removal from the exchange.

What to watch

LiqTech is incorporated in Nevada and operates out of Ballerup, Denmark. The filing states the company is monitoring its closing bid price and considering its options under the Nasdaq Listing Rules. No specific compliance mechanism appears in the filing as of July 24, 2026.

The next confirmable event on the tape: 10 consecutive business days at or above $1.00, or a separate public disclosure naming the company's chosen path to compliance.

About this story

Filed by the macro desk of MarketPR on July 25, 2026. Source: MarketPR. Indicative figures are not investment advice.

Back to the news index